- Home
- LSTA vs BGI Comparison
LSTA vs BGI Comparison
Compare LSTA & BGI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LSTA
- BGI
- Stock Information
- Founded
- LSTA 1980
- BGI 1879
- Country
- LSTA United States
- BGI Canada
- Employees
- LSTA N/A
- BGI N/A
- Industry
- LSTA Misc Health and Biotechnology Services
- BGI
- Sector
- LSTA Health Care
- BGI
- Exchange
- LSTA Nasdaq
- BGI Nasdaq
- Market Cap
- LSTA 24.1M
- BGI 17.8M
- IPO Year
- LSTA N/A
- BGI 2005
- Fundamental
- Price
- LSTA $2.61
- BGI $1.00
- Analyst Decision
- LSTA Strong Buy
- BGI
- Analyst Count
- LSTA 1
- BGI 0
- Target Price
- LSTA $15.00
- BGI N/A
- AVG Volume (30 Days)
- LSTA 15.8K
- BGI 86.0K
- Earning Date
- LSTA 08-11-2025
- BGI 07-15-2025
- Dividend Yield
- LSTA N/A
- BGI N/A
- EPS Growth
- LSTA N/A
- BGI N/A
- EPS
- LSTA N/A
- BGI N/A
- Revenue
- LSTA $1,000,000.00
- BGI $131,596,265.00
- Revenue This Year
- LSTA N/A
- BGI N/A
- Revenue Next Year
- LSTA N/A
- BGI N/A
- P/E Ratio
- LSTA N/A
- BGI N/A
- Revenue Growth
- LSTA N/A
- BGI 4.01
- 52 Week Low
- LSTA $1.87
- BGI $0.76
- 52 Week High
- LSTA $4.20
- BGI $2.95
- Technical
- Relative Strength Index (RSI)
- LSTA 50.61
- BGI 61.49
- Support Level
- LSTA $2.36
- BGI $0.85
- Resistance Level
- LSTA $3.07
- BGI $0.99
- Average True Range (ATR)
- LSTA 0.23
- BGI 0.06
- MACD
- LSTA 0.02
- BGI 0.01
- Stochastic Oscillator
- LSTA 37.50
- BGI 92.86
About LSTA Lisata Therapeutics Inc.
Lisata Therapeutics Inc is a clinical-stage pharmaceutical company dedicated to the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product, certepetide, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively. The group has one operating segment, the research and development of its investigational drug product.
About BGI Birks Group Inc.
Birks Group Inc is a part of the leisure industry. The company designs, develops, produces, and retails fine jewelry, timepieces, and gifts. Its operating segments include Retail and Other. The company generates maximum revenue from the Retail segment. Its retail segment consists of retail operations whereby it operates stores in Canada under the Maison Birks, Brinkhaus, Graff, and Patek Phillippe brands. The other segment consists mainly of wholesale business, e-commerce business, and gold exchange business.